Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.
Vincenti F, Larsen CP, Alberu J, Bresnahan B, Garcia VD, Kothari J, Lang P, Urrea EM, Massari P, Mondragon-Ramirez G, Reyes-Acevedo R, Rice K, Rostaing L, Steinberg S, Xing J, Agarwal M, Harler MB, Charpentier B. Vincenti F, et al. Am J Transplant. 2012 Jan;12(1):210-7. doi: 10.1111/j.1600-6143.2011.03785.x. Epub 2011 Oct 12. Am J Transplant. 2012. PMID: 21992533 Free article. Clinical Trial.
Changes in the commercial brand of tacrolimus lead to subtherapeutic trough levels and acute rejection in renal transplant recipients.
Arreola-Guerra JM, Alberú J, Chew-Wong A, Macias DM, Hernández-Rosales J, Zuñiga-Macías L, Delgadillo-Castañeda R, Ricalde-Ríos G, Haro-Alcalde F, Villafán-Bernal JR, Ramos-Medellín CL, Reyes-Acevedo R. Arreola-Guerra JM, et al. Among authors: reyes acevedo r. Clin Transplant. 2019 Dec;33(12):e13749. doi: 10.1111/ctr.13749. Epub 2019 Nov 26. Clin Transplant. 2019. PMID: 31691354
Immunophenotyping of peripheral immunoregulatory as well as Th17A and Th22 cell subpopulations in kidney transplant recipients under belatacept or cyclosporine treatment.
Furuzawa-Carballeda J, Bostock IC, Lima G, Mancilla-Urrea E, Mondragón G, Reyes-Acevedo R, Chevaile A, Morales-Buenrostro LE, Llorente L, Alberú J. Furuzawa-Carballeda J, et al. Transpl Immunol. 2014 Mar;30(2-3):107-13. doi: 10.1016/j.trim.2014.02.002. Epub 2014 Feb 18. Transpl Immunol. 2014. PMID: 24561014 Clinical Trial.
Tolerability of up to 200 days of prophylaxis with valganciclovir oral solution and/or film-coated tablets in pediatric kidney transplant recipients at risk of cytomegalovirus disease.
Varela-Fascinetto G, Benchimol C, Reyes-Acevedo R, Genevray M, Bradley D, Ives J, Silva HT Jr. Varela-Fascinetto G, et al. Among authors: reyes acevedo r. Pediatr Transplant. 2017 Feb;21(1). doi: 10.1111/petr.12833. Epub 2016 Oct 17. Pediatr Transplant. 2017. PMID: 27753183 Clinical Trial.
Chronic Kidney Disease Risk Profile in Renal Donors in Aguascalientes, Mexico: A Retrospective Cohort Study.
Reza-Escalera AL, Tiscareño-Gutiérrez MT, Ovalle-Robles I, Macias-Guzmán MJ, Garcia-Díaz AL, Gutierrez-Peña CM, Chew-Wong A, Ricalde-Ríos G, Romo-Franco L, Reyes-Acevedo R, Galvan-Guerra E, Lagunas-Rodríguez AB, Delgado-Beltran MI, Rojas-Terán JF, Delgadillo-Castañeda R, Macias-Diaz DM, Alberu-Gomez J, Arreola-Guerra JM. Reza-Escalera AL, et al. Among authors: reyes acevedo r. Transplant Proc. 2022 Sep;54(7):1701-1706. doi: 10.1016/j.transproceed.2021.09.036. Epub 2021 Oct 30. Transplant Proc. 2022. PMID: 34756716
27 results